These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12492253)

  • 1. Local treatment of tendinopathies: a comparison between tropisetron and depot corticosteroids combined with local anesthetics.
    Stratz Th; Färber L; Müller W
    Scand J Rheumatol; 2002; 31(6):366-70. PubMed ID: 12492253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of tendopathies with tropisetron.
    Stratz T; Varga B; Müller W
    Rheumatol Int; 2002 Nov; 22(6):219-21. PubMed ID: 12426658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local treatment of periarthropathies with the 5-HT3-receptor-antagonist tropisetron].
    Stratz T; Stauber A; Müller W
    Z Orthop Ihre Grenzgeb; 2002; 140(4):394-8. PubMed ID: 12183788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local treatment of tendinopathies and myofascial pain syndromes with the 5-HT3 receptor antagonist tropisetron.
    Müller W; Stratz T
    Scand J Rheumatol Suppl; 2004; 119():44-8. PubMed ID: 15515413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone.
    Samborski W; Stratz T; Mackiewicz S; Müller W
    Scand J Rheumatol Suppl; 2004; 119():51-4. PubMed ID: 15515415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local treatment of rheumatic diseases with the 5-HT3 receptor antagonist tropisetron].
    Stratz T; Müller W
    Schmerz; 2003 Jun; 17(3):200-3. PubMed ID: 12789487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of chronic low back pain with tropisetron.
    Stratz T; Müller W
    Scand J Rheumatol Suppl; 2004; 119():76-8. PubMed ID: 15515421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sub-anesthetic doses of bupivacaine or lidocaine increase peripheral ICS-205 930-induced analgesia against inflammatory pain in rats.
    Giordano J; Sacks SM
    Eur J Pharmacol; 1997 Sep; 334(1):39-41. PubMed ID: 9346325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron and tropisetron with dexamethasone in the prophylaxis of acute vomiting induced by non-cisplatin-containing chemotherapy.
    Jantunen IT; Kataja VV; Johansson RT
    Acta Oncol; 1992; 31(5):573-5. PubMed ID: 1419105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia.
    Späth M; Stratz T; Neeck G; Kötter I; Hammel B; Amberger CC; Haus U; Färber L; Pongratz D; Müller W
    Scand J Rheumatol; 2004; 33(4):267-70. PubMed ID: 15370724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous treatment of fibromyalgia with the 5-HT3 receptor antagonist tropisetron in a rheumatological practice.
    Tolk J; Kohnen R; Müller W
    Scand J Rheumatol Suppl; 2004; 119():72-5. PubMed ID: 15515420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients.
    Färber L; Stratz TH; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Welzel D; Müller W;
    Int J Clin Pharmacol Res; 2001; 21(1):1-13. PubMed ID: 11708570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
    Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
    Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group.
    Färber L; Stratz T; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Alten R; Müller W
    Scand J Rheumatol Suppl; 2000; 113():49-54. PubMed ID: 11028832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibromyalgia treatment with intravenous tropisetron administration.
    Stratz T; Färber L; Varga B; Baumgartner C; Haus U; Müller W
    Drugs Exp Clin Res; 2001; 27(3):113-8. PubMed ID: 11447769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of the intravenous administration of tropisetron in fibromyalgia patients.
    Müller W; Stratz T
    Scand J Rheumatol Suppl; 2000; 113():59-62. PubMed ID: 11028834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain.
    Haus U; Varga B; Stratz T; Späth M; Müller W
    Scand J Rheumatol Suppl; 2000; 113():55-8. PubMed ID: 11028833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of the 5-HT3 receptor antagonist tropisetron on pain in fibromyalgia: a functional magnetic resonance imaging pilot study.
    Koeppe C; Schneider C; Thieme K; Mense S; Stratz T; Müller W; Flor H
    Scand J Rheumatol Suppl; 2004; 119():24-7. PubMed ID: 15515408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of tropisetron on the serum substance P levels in fibromyalgia patients.
    Stratz T; Fiebich B; Haus U; Müller W
    Scand J Rheumatol Suppl; 2004; 119():41-3. PubMed ID: 15515412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.